14 January 2020 - The catastrophic expense of high cost drugs have been made affordable for a record number of Canadians, their employers, and life and health insurance companies through the industry’s drug cost sharing mechanism.

The Canadian Drug Insurance Pooling Corporation (CDIPC) announced today that between 2012 and 2018, its 23-member health insurance companies and EP3 cost-sharing framework provided to employers has helped over 45,500 Canadians and their 24,000 employers to afford high cost specialty drugs. This includes over 23,000 Canadians whose treatment required drugs cost in excess of $10,000 per year in 2018.

Growing by 3 to 5% annually, Canadians in need of high cost drugs now represent over 39 per cent of the total drug claims paid being for by CDIPC’s member insurance companies.

Read Canadian Drug Insurance Pooling Corporation press release